The effect of combi...
 
Notifications
Clear all

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells


NA
 NA
(@j)
Joined: 3 years ago
Posts: 531
Topic starter  

https://eurekamag.com/research/065/939/065939144.php

"Current results suggest a potential role of NaPB as a sensitizing agent in NSCLC."


Quote
Topic Tags
Share: